Loading…
BlackRock Health Sciences Trust is projected to rise to $51.03 by 2027, a +29% move from its current price of $39.66. BME is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $39.39 | $39.68 | $39.97 | +0.04% |
| May 30 | $39.28 | $39.69 | $40.11 | +0.08% |
| May 31 | $39.21 | $39.71 | $40.22 | +0.13% |
| Jun 1 | $39.15 | $39.73 | $40.32 | +0.17% |
| Jun 2 | $39.10 | $39.74 | $40.40 | +0.21% |
| Jun 3 | $39.05 | $39.76 | $40.48 | +0.25% |
| Jun 4 | $39.01 | $39.78 | $40.56 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $39.01 | $39.78 | $40.56 | +0.29% |
| Week 2 | $38.81 | $39.89 | $41.01 | +0.59% |
| Week 3 | $38.69 | $40.01 | $41.38 | +0.89% |
| Week 4 | $38.60 | $40.13 | $41.72 | +1.18% |
| Week 5 | $38.53 | $40.25 | $42.04 | +1.48% |
| Week 6 | $38.49 | $40.37 | $42.34 | +1.78% |
| Week 7 | $38.45 | $40.49 | $42.62 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States and seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
The asset is BlackRock Health Sciences Trust (BME), a closed-ended equity mutual fund. Its current price is $39.61 and its market capitalization is $511.92M, with a market rank of 3027. The fund operates within the Financial Services category.
The latest forecast hints at an improving price path after 2026, with the 2026 average price at $39.61, and higher average prices projected in future years as bullish conditions take hold.
A major floor 5.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.6% away) — a key level to hold.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 7.5% above — clearing it would confirm fresh momentum.
Key BME support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BME market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $39.49 | Buy | $39.50 | Buy |
| MA 10 | $39.30 | Buy | $39.37 | Buy |
| MA 20 | $39.22 | Buy | $39.30 | Buy |
| MA 50 | $39.16 | Buy | $39.52 | Buy |
| MA 100 | $40.46 | Sell | $39.75 | Sell |
| MA 200 | $39.45 | Buy | $39.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.46 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 110.36 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 1.77 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.02 | Sell |
| Awesome (5,34) | 0.16 | Buy |
| Ultimate (7,14,28) | 76.71 | Sell |
| Momentum (10) | 0.26 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 39.75 | Sell |
| ADX (14) | 9.61 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture shows a bullish sentiment. RS I 14 is 50, with the price trading near key moving averages: SMA50 at $39.17 and SMA200 at $39.40. Support is at $38.63 and resistance at $40.09. The thirty-day price range spans $37.62 to $41.71, and annualized volatility stands at 10%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $37.67 | $39.66 | $56.49 | 0% | Neutral | |
| $41.69 | $51.03 | $65.39 | +29% | Bullish | |
| $44.71 | $55.73 | $73.27 | +41% | Bullish | |
| $45.84 | $58.00 | $77.84 | +46% | Bullish | |
| $50.43 | $64.66 | $88.31 | +63% | Bullish | |
| $54.18 | $70.30 | $97.52 | +77% | Bullish | |
| $60.02 | $78.75 | $110.78 | +99% | Bullish | |
| $73.25 | $97.13 | $138.38 | +145% | Bullish | |
| $76.72 | $102.73 | $148.10 | +159% | Bullish | |
| $76.15 | $102.92 | $150.00 | +160% | Bullish | |
| $112.90 | $159.13 | $242.98 | +301% | Bullish | |
| $190.28 | $287.59 | $470.57 | +625% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $37.67 | $39.66 | $46.52 | +0.00% |
| June 2026 | $35.11 | $40.96 | $48.71 | +3.28% |
| July 2026 | $35.12 | $41.21 | $49.47 | +0.61% |
| August 2026 | $35.06 | $41.32 | $49.97 | +0.27% |
| September 2026 | $36.39 | $43.04 | $52.36 | +4.16% |
| October 2026 | $37.77 | $44.83 | $54.82 | +4.15% |
| November 2026 | $37.88 | $45.10 | $55.42 | +0.61% |
| December 2026 | $38.34 | $45.77 | $56.49 | +1.49% |
Click any year to see its month-by-month BME forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BME could reach as high as $56.49, with a base case around $39.66 and support toward $37.67 — roughly 0% from $39.66. A consolidation phase looks the most probable path here.
Expect BME to range from $41.69 to $65.39 through 2027. The $51.03 average target implies a +29% move from current prices. That is up +29% on the projected 2026 average. Momentum favours further upside here.
The BME price prediction for 2028 points to an average of $55.73 (low $44.71, high $73.27) — a potential gain of +41% on today's $39.66. Buyers look set to stay in control over this stretch.
In 2029, BME is projected to trade between $45.84 and $77.84, averaging $58.00 — a potential gain of +46% from today's $39.66. That is up +4% on the projected 2028 average. Momentum favours further upside here.
BlackRock Health Sciences Trust's 2030 outlook centres on $64.66, within a $50.43 to $88.31 range. That is up +11% on the projected 2029 average. That marks a +63% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, BME could reach as high as $97.52, with a base case around $70.30 and support toward $54.18 — roughly +77% from $39.66. Momentum favours further upside here.
Expect BME to range from $60.02 to $110.78 through 2032. The $78.75 average target implies a +99% move from current prices. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The BME price prediction for 2033 points to an average of $97.13 (low $73.25, high $138.38) — a potential gain of +145% on today's $39.66. Momentum favours further upside here.
In 2034, BME is projected to trade between $76.72 and $148.10, averaging $102.73 — a potential gain of +159% from today's $39.66. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
BlackRock Health Sciences Trust's 2035 outlook centres on $102.92, within a $76.15 to $150.00 range. That is up 0% on the projected 2034 average. That marks a +160% change versus current levels. Momentum favours further upside here.
By 2040, BME could reach as high as $242.98, with a base case around $159.13 and support toward $112.90 — roughly +301% from $39.66. Buyers look set to stay in control over this stretch.
Expect BME to range from $190.28 to $470.57 through 2050. The $287.59 average target implies a +625% move from current prices. That is up +81% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BME today (≈ 25.214322 BME) could be worth
$7,251.3
+$6,251.3 (+625%) by 2050 · US Dollar
Based on the average projected BME price of $287.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMEwould be worth at today's price.
$1,000 invested in BME on May 27, 2025 (≈ 27.940765 BME) would be worth
$1,108.13
+$108.13 (+10.8%) today · 1.11× · US Dollar
Based on a BME entry price of $35.79 vs. today's $39.66.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $39.27 | $1,009.93 | +1.0% |
| 1 month ago | $39.07 | $1,015.1 | +1.5% |
| 3 months ago | $42.3 | $937.59 | -6.2% |
| 6 months ago | $41.53 | $954.97 | -4.5% |
| 1 year ago | $35.79 | $1,108.13 | +10.8% |
| All time (5.0y) ago | $47.4 | $836.71 | -16.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BME forecast.
Our base-case forecast reaches $79.00 around 2033.
Implied market cap at $79.00: $1.02B
The multi-year forecast paints a bullish path beyond 2026, with notable milestones. The 2027 average price is $51.01 (ROIPct 28.8) and the 2030 average price is $64.66 (ROIPct 63.3), both with bullish sentiment. By 2040, the average forecast reaches $158.94 (ROIPct 301.3), and by 2050 the average forecast is $289.29 (ROIPct 630.4), all with bullish sentiment.
These figures imply substantial longer-term upside but remain estimates and not guarantees; actual results will depend on market conditions, sector performance, and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $64.66 with ROIPct 63.3 and sentiment BULLISH.
Forecasts show a bullish path from 2027 onward, with the average price rising to $51.01 in 2027 and reaching $289.29 in 2050, with ROIPct up to 630.4 and sentiment consistently BULLISH. These are estimates, not guarantees.
Yes. The forecast for 2033 shows an average price of $97.38 and 2034 shows an average price of $102.51 with a max of $147.80, indicating potential to exceed $100 around 2034.
Current price: $39.61. Market cap: $511.92M.
Thirty-day range is from $37.62 to $41.71.
BlackRock Health Sciences Trust Community Discussion
0Share your BlackRock Health Sciences Trust price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.